
Lotus Eye Hospit Sees Revision in Market Assessment Amid Mixed Financial Signals
2025-12-03 11:08:04Lotus Eye Hospit has experienced a revision in its market evaluation, reflecting a shift in analytical perspective driven by a combination of financial trends, valuation considerations, and technical factors. Despite challenges in profitability and valuation metrics, the stock’s recent performance relative to the broader market has drawn renewed attention.
Read MoreWhy is Lotus Eye Hospit falling/rising?
2025-11-17 23:36:10As of 17-Nov, Lotus Eye Hospital & Institute Ltd is experiencing a decline in its stock price, currently at 106.50, reflecting a decrease of 4.45 points or 4.01%. The stock has been underperforming recently, having fallen consecutively for the last three days, resulting in a total decline of 11.95% during this period. Today, it opened with a loss of 4.87% and reached an intraday low of Rs 105.55. The stock's performance over the past week and month shows a significant downturn, with returns of -9.75% and -9.82%, respectively, while it has performed well year-to-date and over the past year, with increases of 54.73% and 63.85%. There is no information available regarding positive or negative factors that could be influencing the stock's recent movement. Broader Market Context: In comparison to the benchmark, the Sensex has gained 1.69% over the past week, while Lotus Eye Hospital's stock has seen a decline o...
Read More
Lotus Eye Hospital Stock Hits Lower Circuit Limit at Rs 109.17, Declines 5% Intraday
2025-11-14 14:00:09Lotus Eye Hospital & Institute Ltd experienced significant trading activity today, hitting its lower circuit limit and closing at Rs 112.50. The stock has underperformed its sector and faced a consecutive decline over the past two days. Increased delivery volume suggests rising investor participation despite recent challenges.
Read More
Lotus Eye Hospital Q2 FY26: Profitability Under Pressure Despite Stable Revenue
2025-11-14 09:39:15Lotus Eye Hospital & Institute Ltd., a Coimbatore-based speciality eye care provider, reported a challenging quarter for Q2 FY26 (July-September 2025), with net profit declining to ₹0.12 crores from ₹0.54 crores in the previous quarter, marking a sharp 77.78% sequential contraction. On a year-over-year basis, net profit rose modestly by 20.00% from ₹0.10 crores in Q2 FY25. The company's stock, currently trading at ₹111.00, has declined 3.56% following the results announcement, reflecting investor concerns about deteriorating margins and operational efficiency.
Read MoreHow has been the historical performance of Lotus Eye Hospit?
2025-11-13 23:43:50Answer: The historical performance of Lotus Eye Hospital shows a mixed trend over the years, with fluctuations in revenue and profit metrics. Breakdown: Lotus Eye Hospital's net sales have shown a steady increase from INR 32.37 crore in March 2021 to INR 49.56 crore in March 2025, with a notable rise from INR 38.91 crore in March 2022. Total operating income has mirrored this trend, reaching INR 49.56 crore in March 2025. However, the total expenditure has also increased significantly, from INR 28.81 crore in March 2021 to INR 46.13 crore in March 2025, impacting operating profit, which fell from INR 7.58 crore in March 2023 to INR 3.43 crore in March 2025. Consequently, profit before tax decreased from INR 5.65 crore in March 2023 to INR 1.38 crore in March 2025, with profit after tax also declining from INR 4.08 crore to INR 0.74 crore during the same period. The company's total assets rose from INR 57.2...
Read MoreWhy is Lotus Eye Hospit falling/rising?
2025-11-13 23:34:08As of 13-Nov, Lotus Eye Hospital & Institute Ltd's stock price is currently at 115.00, reflecting a decline of 5.95 points or 4.92%. The stock has underperformed its sector by 4.69% today and opened with a loss of 4.88%. It reached an intraday low of Rs 115, indicating a significant drop. Additionally, the stock's delivery volume has decreased dramatically, falling by 84.55% compared to the 5-day average, suggesting a decline in investor participation. While the stock has shown strong performance year-to-date with a gain of 67.08% and a one-year increase of 79.66%, it has recently struggled, with a 1-week decline of 5.93% and a 1-month drop of 6.35%. There is no information available regarding positive or negative factors impacting the stock. Broader Market Context: In comparison to the benchmark Sensex, which has increased by 1.40% over the past week and 2.61% over the past month, Lotus Eye Hospital's rec...
Read MoreHow has been the historical performance of Lotus Eye Hospit?
2025-11-13 00:33:06Answer: The historical performance of Lotus Eye Hospital shows a mixed trend over the years, with fluctuations in revenue and profit metrics. Breakdown: Lotus Eye Hospital's net sales have shown a steady increase from INR 32.37 crore in March 2021 to INR 49.56 crore in March 2025. Total operating income followed a similar trend, reaching INR 49.56 crore in March 2025, up from INR 38.91 crore in March 2022. However, total expenditure has also risen, from INR 28.81 crore in March 2021 to INR 46.13 crore in March 2025, impacting operating profit, which decreased from INR 7.58 crore in March 2023 to INR 3.43 crore in March 2025. Profit before tax similarly declined from INR 5.65 crore in March 2023 to INR 1.38 crore in March 2025, leading to a profit after tax of INR 0.74 crore in March 2025, down from INR 4.08 crore in March 2023. The company's total assets increased from INR 57.26 crore in March 2020 to INR ...
Read MoreWhy is Lotus Eye Hospit falling/rising?
2025-11-06 23:36:41As of 06-Nov, Lotus Eye Hospital & Institute Ltd is currently priced at 124.50, reflecting a decrease of 0.75, or 0.6%. The stock has been experiencing a decline, having lost 4.16% over the last two days. Despite this recent downturn, the stock has shown strong performance over longer periods, with a year-to-date increase of 80.88% and a five-year growth of 314.31%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive trend prior to the recent falls. There is also a notable increase in investor participation, with delivery volume rising by 89.04% compared to the 5-day average, suggesting continued interest in the stock despite its short-term decline. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, the sto...
Read MoreWhy is Lotus Eye Hospit falling/rising?
2025-11-03 23:18:50As of 03-Nov, Lotus Eye Hospital & Institute Ltd is experiencing a price increase, currently at Rs 130.35, which reflects a rise of Rs 6.2 or 4.99%. The stock has shown strong performance today, outperforming its sector by 3.61% and has been on a consecutive gain streak for the last three days, accumulating a total return of 9.86% during this period. Despite opening lower with a loss of 2.01%, the stock reached an intraday high of Rs 130.35. It is also trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 38.99% compared to the 5-day average, suggesting growing interest in the stock. In the broader market context, Lotus Eye Hospital has significantly outperformed the benchmark Sensex over various time frames, including a 7.86% gain over the past wee...
Read MoreAnnouncement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
02-Dec-2025 | Source : BSEImposition of fine
Announcement under Regulation 30 (LODR)-Newspaper Publication
13-Nov-2025 | Source : BSEof the financial results approved by the Board of Directors in its meeting held on 12th November 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On November 12Th 2025
12-Nov-2025 | Source : BSEapproval of unaudited financial results for the quarter and year ended 30th September 2025
Corporate Actions
No Upcoming Board Meetings
Lotus Eye Hospital & Institute Ltd has declared 5% dividend, ex-date: 18 Sep 23
No Splits history available
No Bonus history available
No Rights history available






